|
Central Obesity and Disease Risk in Japanese Americans Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Central Obesity and Disease Risk in Japanese Americans conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Central Obesity and Disease Risk in Japanese Americans Clinical research trials and Central Obesity and Disease Risk in Japanese Americans medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Central Obesity and Disease Risk in Japanese Americans. Central Obesity and Disease Risk in Japanese Americans Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Central Obesity and Disease Risk in Japanese Americans clinical trial. Subjects often receive the most expert healthcare possible for their Central Obesity and Disease Risk in Japanese Americans condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Central Obesity and Disease Risk in Japanese Americans  Central Obesity and Disease Risk in Japanese Americans
Central Obesity and Disease Risk in Japanese Americans
For Condition: Insulin Resistance,Heart Diseases,Hypertension,Diabetes Mellitus, non-insulin dependent,Metabolic Syndrome X,Atherosclerosis,Obesity,Diabetes Mellitus,Hyperinsulinism,Coronary Arteriosclerosis,Cardiovascular Diseases
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To conduct a longitudinal study of central obesity and related risk factors found to be associated with hypertension and atherosclerotic cardiovascular disease (ASCVD) in a previously-examined cross-sectional cohort of second-generation Japanese Americans and in a newly-recruited cohort of third generation Japanese Americans.
Details: BACKGROUND: The study was conducted in response to a program announcment issued in 1991 on obesity and tests the hypothesis that atherosclerotic cardiovascular disease (ASCVD), hypertension, and/or non-insulin dependent diabetes mellitus (NIDDM) develop in Japanese Americans when there is a truncal pattern of weight gain (central adiposity), which is in turn accompanied by insulin resistance, hyperinsulinemia, and lipid abnormalities. This cluster of abnormalities has been called 'Syndrome X'. It is postulated that 'Syndrome X' develops in Japanese Americans in response to environmental (behavioral) factors, many of which reflect 'westernization' in this ethnic group. The research plan focuses upon the relationship between central obesity and metabolic changes and disease outcomes associated with 'Syndrome X' along with the behavioral variables that potential risk factors for the development of this cluster of abnormalities. DESIGN NARRATIVE: The cohort was re-examined for diabetes, hypertension, coronary heart, disease, peripheral vascular disease, and a number of potential coronary heart disease risk factors including medical history, health practice, social history, diet, glycosylated hemoglobin, insulin, proinsulin, c-peptide, glucose, anthrometric measurements, lipids, and computed tomography on the thorax, abdomen, and thigh.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: 45 Years/74 Years
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
WilfredFujimoto, , University of Washington
Additional Information:
Study ID Numbers: 4252;
Study Start Date: February 1993
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005365
Other Diabetes Mellitus Studies:
1. High Density Lipoprotein Subspecies and Coronary Disease
2. Multi-Ethnic Study of Atherosclerosis (MESA)
3. Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA
4. Women's Angiographic Vitamin and Estrogen Trial (WAVE)
5. Apolipoprotein Polymorphisms and Risk of Coronary Heart Disease
Related Studies:
Other Diabetes Mellitus Clinical Trials
Other Clinical Trials
Other Clinical Trials
Central Obesity and Disease Risk in Japanese Americans
|
|
|
|
|
|
|
|
